There will be no change in anything until GCAN provides verified results. The company is currently in the same position as many MJ start up companies that talk about products that would be nice to have and to sell. The only problem is that most have products that are never produced or sold. The dot.com boom/bust came and went now the MJ boom/bust seems to be happening and GCAN seems to be a little late to the party, with a product that can't get produced. Is symtomax our savior? I doubt it, if gcan technology was as good as advertised we would already be producing the patch and selling it. The dream team would have already found a way to get a product to market with out sharing the $$, people are greedy.
News 
Market Data 
Discover 
